Ameliorative effect of daidzein: A caveolin-1 inhibitor in vascular endothelium dysfunction induced by ovariectomy

Indian Journal of Experimental Biology

Volumn 50, Issue 1, 2012, Pages 28-34

  Sharma, Saurabh ^a   Singh, Manjeet ^a   Sharma, Pyare Lal ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Caveolin; Estrogen; Ovariectomy; Vascular endothelium dysfunction

Indexed keywords

ACETYLCHOLINE; CAVEOLIN 1; DAIDZEIN; ISOFLAVONE DERIVATIVE; NITRATE; NITRITE; NITROPRUSSIDE SODIUM; PHYTOESTROGEN; VASODILATOR AGENT;

ANIMAL; AORTA DISEASE; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; METABOLISM; OVARIECTOMY; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; AORTIC DISEASES; CAVEOLIN 1; ENDOTHELIUM, VASCULAR; FEMALE; ISOFLAVONES; NITRATES; NITRITES; NITROPRUSSIDE; OVARIECTOMY; PHYTOESTROGENS; RATS; RATS, SPRAGUE-DAWLEY; VASODILATION; VASODILATOR AGENTS;

ANIMALIA; RATTUS;

EID: 84855288586     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Endemann H D & Ernesto L S, Endothelial dysfunction J Am Soc Nephrol, 15(2004) 1983.
2. Esper R J, Roberto A N, Jorge O V, Antonio P, José L C & Rogelio A M, Endothelial dysfunction: A comprehensive appraisal Cardiovasc Diabetol, 5 (2006) 4.
3. Taddie S, Virdis A, Ghiadoni L, Sudano I & Salvetti A Endothelial dysfunction in hypertension J Cardiovasc Pharm 38 (2001) S11
4. Sainani G S & Maru V G, Role of endothelial dysfunction in essential hypertension, JAPI, 52 (2004) 966.
5. Caramori P R A & Zago A J, Endothelial dysfunction & coronary artery disease Arg Bras Cardiol, 75 (2000) 173.
6. Spieker L E, Luscher T F & Noll G, Current strategies & perspectives for correcting endothelial dysfunction in atherosclerosis, J Cardiovasc Pharm, 38, (2001) S35.
7. Haorah J, Ramirez S H, Schall K, Smith D, Pandya R, Persidsky Y, Oxidative stress activates protein tyrosine kinase & matrix metalloproteinases leading to blood-brain barrier dysfunction, Journal of Neurochemistry 101(2) (2007) 566.
8. Faraci F M & Lentz S R, Hyperhomocysteinemia, oxidative stress & cerebral vascular dysfunction, Stroke, 35 (2004) 345.
9. De Vriese A S, Verbeuren T J, Vande V J, Lameire N H & Vanhoutte P M, Endothelial dysfunction in diabetes, Br J Phamacol, 130 (2000) 963.
10. Nakagami H, Kaneda Y, Ogihara T & Morishita R, Endothelial dysfunction in hyperglycemia as a trigger of atheroscelerosis, Curr Diabet Rev, I (2005) 59.
11. Levin R E, Integration of the extra-nuclear & nuclear actions of estrogen, Mol Endocrin, 19 (2005) 1951.
12. Chambliss K L & Shaul P W, Estrogen modulation of endothelial nitric oxide synthase, Endocr Rev, 23(5) (2002) 665.
13. Raghvendra K D, Bruno I, Matthias B & Edwin K J, Vascular consequences of menopause & hormone therapy: Importance of timing of treatment & type of estrogen, Cardiovasc Res, 66 (2005) 295.
14. Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R & Saruta T, Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells, FEBS Lett, 360 (1995) 291.
15. 2+ Calmodulin & caveolin J Bio Chem, 272(25) (1997) 15583.
16. Rubanyi G M, Freay A D, Kauser K, Sukovich D, Burton G, Lubahn D B, Couse J F, Curtis S W & Korach K S, Vascular estrogen receptors & endothelium-derived nitric oxide production in the mouse aorta Gender difference & effect of estrogen receptor gene disruption, J Clin Invest, 99 (1997) 2429.
17. Razi M, Pedram A, Greene G L & Levin E R, Cell membrane & nuclear estrogen receptors (ERs) originate from a single transcript: studies of ER & ERß expressed in Chinese hamster ovary cells Mol Endocrinol, 13 (1999) 307.
18. Chen Y Z & Qiu J, Pleiotropic signaling pathways in rapid, nongenomic action of glucocorticoid, Mol Cell Biol Res Commun, 2 (1999) 145.
19. Hisamoto K, Ohmichi M, Kurachi H, Hayakawa J, K Y, Nishio Y, Adachi K, Tasaka K, Miyoshi E, Fujiwara N, Taniguchi N & Murata Y, Estrogen induces the Aktdependent activation of endothelial nitric-oxide synthase in vascular endothelial cells J Biol Chem, 276 (2001) 3459.
20. Simoncini T, Hafezi-Moghadam, A, Brazil D P, Ley K, Chin W W & Liao J K, Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase, Nature, 407 (2000) 538.
21. Gratton J P, Fontana J, O'Connor D S, Garcia-Cardena G, Mccabe T J & Sessa W C, Reconstitution of endothelial nitric oxide synthase, Hsp90 & caveolin-1 complex in vitro: evidence that Hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1 J Biol Chem, 275 (2000) 22268.
22. Smart E J, Graf G A, McNiven MA, Sessa W C, Engelman J A, Scherer P W, Okamoto T & Lisanti M P, Caveolins, liquid-ordered domains & signal transduction, Mol Cell Biol, 19 (1999) 7289.
23. Sharma S, Singh M & Sharma PL, Beneficial effect of insulin in hyperhomocysteinemia & diabetes mellitusinduced vascular endothelium dysfunction: role of phosphoinositide dependent kinase & protein kinase B, Mol Cell Biochem, 348 (2011) 21.
24. Fulton D, Gratton J P & Sessa W C, Post-translational control of endothelial nitric oxide synthase: Why isn't calcium/calmodulin enough? J Pharmacol Exp Ther, 299 (2001) 818.
25. Minshall R D, Tiruppathi C, Vogel S M & Malik A B, Vesicle formation & trafficking in endothelial cells & regulation of endothelial barrier function, Histochem Cell Biol, 117 (2002) 105.
26. Elçioglu K H, Kabasakal L, Cetinel S, Conturk G, Sezen S F & Ayanoglu-Dulger G Changes in caveolin-1 expression & vasoreactivity in the aorta & corpus cavernosum of fructose & streptozotocin-induced diabetic rats Eur J Pharmacol 642(2010) 113.
27. Xu B, Zhu GH, Weng JF, Cai WS, Xia JT & Li SH The roles of caveolin-1 & endothelial nitric oxide synthase in the development of portal hypertension in rats with liver cirrhosis Zhonghua Gan Zang Bing Za Zhi 16 (2008) 184.
28. Pelligrino DA, Ye S, Tan F, Santizo R A, Feinstein D L & Wang Q, No-dependent piol reticular dilation in the female rat: Effects of chemic estrogen depletion & repletion, Biochem Biophys Res Commun, 269 (2000) 165.
29. Sobey G C, Jane M W, Mirna B & Owen L W, Effect of short term phytoestrogen treatment is male rat on nitric oxide mediated responses of carotid & cerebral arteries: Comparison with 17 β estradiol, JPET, 310 (2004) 35.
30. Woodman LO, Melinda A M & Mirna B, Daidzein & 17 estradiol enhance nitric oxide synthatase activity associated with an increase in calmodulin & a decrease in caveolin-1, J Cardiovasc Pharmacol, 44 (2) (2004)
31. Catania M A, Crupi A, Firenzuoli F, Parisi A, Sturiale A, Squadrito F, Caputi A P & Calapai G, Oral administration of a soy extract improves endothelial dysfunction in ovariectomized rats Planta Med,68(12)(2002) 1142.
32. Mitra S & Singh M, Possible mechanism of captopril induced endothelium dependent relaxation in isolated rabbit aorta, Mol Cell Biochem, 183(1998) 63.
33. Auck-Schwelk W, Katusic Z S & Vanhoutte P M, Nitric oxide inactivates endothelium derived contracting factor in the rat aorta, Hypertension, 19 (1992) 442.
34. Sastry K V H, Moudgal R P, Mohan J, Tyagi J S & Rao G S Spectrophotometric determination of serum nitrite & nitrate by copper cadmium alloy, Anal Biochem, 306 (2002) 79.
35. Ohkawa H, Ohishi N & Yagi K Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction, Anal Biochem, 95 (1979) 351.
36. Moya M, Campana V, Gavotto A, Spitale L, Simes J & Palma J, Histopathological lesions in aorta from rats with hiperfrinogenemia published by 2nd virtual congress of cardiology (1999).
37. Shah D I & Singh M, Inhibition of Protein tyrosin Phosphatase improves vascular endothelial dysfunction, Vascular Pharmacology,44(2006) 177.
38. Furchgott R F & Zawadski J V, The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature, 288 (1980) 373.
39. Furcgott R F, The discovery of endothelium-dependent relaxation, Circulation, 87 (1993) V3.
40. Furchgott R F, The 1989 Ulf von Euler Lecture: studied on endothelium dependent vasodilatation & the endotheliumderived relaxing factor Acta Physiol Sci, 139 (1990) 257.
41. Iwama Y, Kato T, Muramatsu M, Asano H, Shimizu K, Toki Y, Miyazaki Y, Okumura K, Hashimoto H, Ito T & Satake T, Correlation with blood pressure of the acetylcholine-induced endothelium-derived contracting factor in the rat aorta, Hypertension, 19 (1992) 326.
42. Janerw D R, Malondialdehyde & thiobarbituric acid reactivity as diagnostic indices of lipid peroxidation & peroxidative tissue injury, Free Radic Biol Med, 9(1990) 515.
43. Wolfrum S, Jensen K & Liao J K, Endothelium-dependent effects of statins, Arteriosceler Thromb Vasc Biol, 23 (2003) 729.
44. Feron O, Dessy D, Jean-Pierre Desager J L & Ballig M D Hydroxy-methylglutaryl-coenzyme a reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance, Circulation, 103 (2001) 113
45. Virdiss A, Lorenzo G, Stefania P, Maurizio L, Felice P L, andrea G, Simona B, Stefano T & Antoni S, Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women, Circulation, 101 (2000) 2258.
46. Zhang X, Li H, Jin H, Ebin Z, Brodsky S & Goligorsky M S, Effects of homocysteine on endothelial nitric oxide production, Am J Physiol Renal Physiol, 279 (2000) F671.
47. Gryglewski R J, Palmer R M & Moncada S, Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor, Nature, 320 (1986) 454.